供者骨髓来源巨噬细胞MHC II驱动慢性GVHD小鼠神经炎症和行为改变
本研究探讨慢性移植物抗宿主病(cGVHD)中枢神经系统(CNS)病变机制。小鼠cGVHD模型显示行为缺陷、广泛神经炎症和持续Ifng上调,供者骨髓来源MHC II+巨噬细胞浸润是CNS cGVHD特征,MHC II敲除可减轻神经炎症和行为异常。
要点
- 供者骨髓来源巨噬细胞(BMDM)浸润是CNS cGVHD的突出特征,占CNS髓系细胞群体高达50%。
- 供者BMDM表达MHC II对CNS cGVHD神经炎症和行为缺陷起关键作用。
- CNS cGVHD与急性GVHD的神经炎症介质不同,需探索晚期神经表现的新治疗靶点。
核心结论
- 供者骨髓来源巨噬细胞的MHC II表达驱动慢性GVHD小鼠的中枢神经炎症和行为改变。
研究设计与样本
- 小鼠cGVHD模型研究,采用流式细胞术、RNA测序及MHC II敲除骨髓移植实验。
主要发现
- 小鼠cGVHD出现行为缺陷,伴广泛神经炎症和持续Ifng上调。
- cGVHD脑内供者T细胞群体从早期CD8优势转为后期CD4隔离。
- 海马RNA测序显示突触相关基因表达紊乱及干扰素-γ反应和抗原呈递基因上调。
- 供者BMDM占CNS髓系群体高达50%,转录特征不同于驻留小胶质细胞。
- MHC II敲除骨髓移植受体神经炎症减轻,行为与对照相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Graft-versus-host disease (GVHD) remains the leading cause of nonrelapse mortality after allogeneic stem cell transplantation for hematological malignancies. Manifestations of GVHD in the central nervous system (CNS) present as neurocognitive dysfunction in up to 60% of patients; however, the mechanisms driving chronic GVHD (cGVHD) in the CNS are yet to be elucidated. Our studies of murine cGVHD revealed behavioral deficits associated with broad neuroinflammation and persistent Ifng upregulation. By flow cytometry, we observed a proportional shift in the donor-derived T-cell population in the cGVHD brain from early CD8 dominance to later CD4 sequestration. RNA sequencing of the hippocampus identified perturbations to structural and functional synapse-related gene expression, together with the upregulation of genes associated with interferon-γ responses and antigen presentation. Neuroinflammation in the cortex of mice and humans during acute GVHD was recently shown to be mediated by resident microglia-derived tumor necrosis factor. In contrast, infiltration of proinflammatory major histocompatibility complex (MHC) class II+ donor bone marrow (BM)-derived macrophages (BMDMs) was identified as a distinguishing feature of CNS cGVHD. Donor BMDMs, which composed up to 50% of the CNS myeloid population, exhibited a transcriptional signature distinct from resident microglia. Recipients of MHC class II knockout BM grafts exhibited attenuated neuroinflammation and behavior comparable to controls, suggestive of a critical role of donor BMDM MHC class II expression in CNS cGVHD. Our identification of disease mediators distinct from those in the acute phase indicates the necessity to pursue alternative therapeutic targets for late-stage neurological manifestations.
引用
- Adams RC, Carter-Cusack D, Shaikh SN, et al. Donor bone marrow-derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice. Blood. 2022. PMID: 34570880. doi:10.1182/blood.2021011671
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。